| Detailed information |
|---|
| CancerLivER ID | 2180 |
| Biomarker | circCDK13 |
| Biomarker Name/Symbol (given in Publication) | circCDK13 |
| Biomolecule | circRNAs |
| Subject | Human |
| Degree of Validity | Biomarker for liver cancer diagnosis and treatment; but not validated on independent patient cohort |
| Experimental Condition | Normal cell line vs cancer cell line |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Suppressed expression in liver cancer |
| Level of significance | p < 0.05 |
| Source | Tissue |
| PMID | 29658568 |
| Type of Biomarker | Diagnostic |
| Pathway | Janus tyrosine kinase (JAK)/signal transducer and activator of transcription (STAT) and phosphoinositide 3-kinase (PI3K)/AKT signaling pathways. |
| Cohort | Liver cancer cell lines, HepG2, Huh7 and SK-Hep1 and tissue samples collected from 62 patients with hepatocellular carcinoma |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human liver cancer |
| Year of Publication | 2018 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |